Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China.
Stock data | 2024 | Change |
---|---|---|
Price | $5.17 | N/A |
Market Cap | $702.81M | N/A |
Shares Outstanding | 136.06M | N/A |
Employees | 439.00 | N/A |